With regard to cellular cortisol signaling, there is no evidence of resistance to cortisol action since patients with COVID-19 exhibit increased expression of both GCR-α and GILZ compared to non-COVID-19 patients with critical diseases of comparable severity. The gene discussed is TSC22D3; the disease is COVID-19.